<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Canadian cannabis giant Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) reported a plunge in third-quarter sales months ago, in addition to a negative adjusted EBITDA of CA$24 million ($28.3 million). At the time, Cantor Fitzgerald’s analyst Pablo Zuanic lowered his price target to CA$9.00 from CA$11.25 while keeping a “Neutral” rating on Aurora’s stock.
...read full article on Benzinga
